Radiation Dose De-Escalation in HPV-Positive Oropharynx Cancer: When Will It Be an Acceptable Standard of Care?

被引：10
|
作者：
Chundury, Anupama [1 ]
Kim, Sung [1 ]
机构：
[1] Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08831 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 09期
关键词：
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; HEAD; SURVIVAL; TRIAL;
D O I：
10.1200/JCO.21.00017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma
    Gabani, Prashant
    Lin, Alexander J.
    Barnes, Justin
    Oppelt, Peter
    Adkins, Douglas R.
    Rich, Jason T.
    Zevallos, Jose P.
    Daly, Mackenzie D.
    Gay, Hiram A.
    Thorstad, Wade L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 134 : 81 - 88
  • [2] De-escalation concepts for chemoradiotherapy of HPV-positive oropharyngeal carcinomas: pros and cons
    Ruehle, A.
    Nicolay, N. H.
    HNO, 2021, 69 (04) : 278 - 284
  • [3] De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
    Golusinski, Pawel
    Corry, June
    Vander Poorten, Vincent
    Simo, Ricard
    Sjogren, Elisabeth
    Makitie, Antti
    Kowalski, Luis Paulo
    Langendijk, Johannes
    Braakhuis, Boudewijn J. M.
    Takes, Robert P.
    Coca-Pelaz, Andres
    Rodrigo, Juan P.
    Willems, Stefan M.
    Forastiere, Arlene A.
    De Bree, Remco
    Saba, Nabil F.
    Teng, Yong
    Sanabria, Alvaro
    Di Maio, Pasquale
    Szewczyk, Mateusz
    Ferlito, Alfio
    ORAL ONCOLOGY, 2021, 123
  • [4] Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?
    Cmelak, Anthony J.
    Ferris, Robert L.
    Chen, Allen M.
    Seiwert, Tanguy
    Burtness, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (24) : 2732 - +
  • [5] Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer
    White, Richard
    Abel, Stephen
    Hasan, Shaakir
    Verma, Vivek
    Greenberg, Larisa
    Colonias, Athanasios
    Wegner, Rodney E.
    LARYNGOSCOPE, 2020, 130 (04) : E171 - E176
  • [6] Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer
    Mavroidis, Panayiotis
    Price, Alex
    Fried, David
    Kostich, Mark
    Amdur, Robert
    Mendenhall, William
    Liu, Chihray
    Das, Shiva
    Marks, Lawrence B.
    Chera, Bhishamjit
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (02) : 240 - 247
  • [7] Is treatment de-escalation a reality in HPV related oropharyngeal cancer?
    Oosthuizen, J. C.
    Kinsella, J. B.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2016, 14 (04): : 180 - 183
  • [8] Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives
    Mirghani, H.
    Amen, F.
    Blanchard, P.
    Moreau, F.
    Guigay, J.
    Hartl, D. M.
    St Guily, J. Lacau
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (07) : 1494 - 1503
  • [9] What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials
    Mensour, Emma A.
    Alam, Shintha
    Mawani, Seliya
    Bahig, Houda
    Lang, Pencilla
    Nichols, Anthony
    Palma, David A.
    Jasper, Katie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction
    Wu, Clinton
    Kuzmin, Paulina
    Julian, Ricklie
    CANCERS, 2024, 16 (15)
12345